CRISPR ethics is an increasingly urgent topic in today’s medical discourse, particularly as advancements in gene editing technology offer both remarkable potentials and daunting ethical dilemmas.As we stand on the verge of addressing genetic conditions such as sickle cell disease, the conversation grows around not just the scientific capabilities, but also the moral implications of editing the human genome.